Julie Eastland

Julie Eastland is the current director at Dynavax Technologies. Julie has also held positions at Graybug Vision, Inc., Eastland Advisory Services, and Harpoon Therapeutics. Eastland's most recent position was at Rainier Therapeutics where they served as the Chief Financial and Business Officer from January 2018 to December 2020. While at Rainier, Eastland provided leadership in the development of the company as they worked to create a new therapy for patients with bladder cancer. In March 2020, the program was sold to an undisclosed third party.

Julie Eastland has an MBA in International Finance from Edinburgh Business School, Heriot-Watt University, and a BS in Finance from Colorado State University.